Detecting early signs of Alzheimer's disease through eye imaging
Validation of Retinal Abeta as a Potential Biomarker of Alzheimer's Disease
This study is looking at a new way to spot early signs of Alzheimer's disease by using special imaging to see certain markers in the eye, which could help catch the disease sooner and make it easier for people to get the help they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10670340 on NIH RePORTER |
What this research studies
This research investigates a new method to detect early signs of Alzheimer's disease by imaging beta-amyloid plaques in the retina using curcumin fluorescence. The approach aims to identify these plaques before significant symptoms appear, allowing for earlier intervention. By utilizing ophthalmology centers for routine screenings, the study seeks to make early detection practical and accessible. This could lead to improved treatment outcomes for patients at risk of Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who may be at risk for Alzheimer's disease, particularly those showing early cognitive decline.
Not a fit: Patients who are already diagnosed with advanced Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enable earlier diagnosis and intervention for Alzheimer's disease, potentially slowing its progression.
How similar studies have performed: Other research has shown promise in using similar imaging techniques for early detection of Alzheimer's, indicating potential for success in this approach.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Pham, Wellington — Vanderbilt University Medical Center
- Study coordinator: Pham, Wellington
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.